The regulatory network of virulence factors production by Staphylococcus aureus, an 23 opportunistic pathogen, is incompletely understood, and the functions of many 24 uncharacterized genes in its genome remain to be uncovered. We screened 380 25 function unassigned genes disrupted mutants of the community-acquired methicillin-26 resistant S. aureus USA300 for pathogenicity using silkworms and identified 11 27 strains with reduced silkworm killing ability. Nine out of the 11 strains displayed 28 reduced virulence in the mouse model as evidenced by reduced colony-forming units 29 in organs of the infected mice. Three of the identified gene-disrupted mutants had 30 reduced hemolytic activity, one among the three also had reduced proteolytic activity 31 and pigment production. These results suggest that silkworm model could identify 32 the genes required for virulence in the mouse model. The newly identified genes 33 involved in virulence in this study facilitates the further understanding of the 34 pathogenicity of S. aureus. 35
Introduction 46
Staphylococcus aureus is a commensal and an opportunistic pathogen that is responsible for ailments ranging from skin infection to deep tissue infection, Use of mouse models for screening of virulence factors is impractical due to high 71 costs and the associated ethical issues. Therefore, utilization of a model that has 72 less ethical issues, resembles a mouse systemic infection model, and allows 73 quantitative analysis of virulence is desired. Here, we used silkworms (Bombyx mori) 74
to uncover the roles of uncharacterized genes of S. aureus in pathogenicity. We 75 have previously shown that injection of S. aureus kills the silkworms(20) and 76 activates innate immunity (21) . We can evaluate the therapeutic effectiveness of 77 antibiotics using silkworm infection model by comparison of effective dose fifty (ED50) 78 values of clinically used antibiotics between silkworms and mammals (22) . On the 79 basis of these advantages, we used silkworms to discover various antibacterial 80 agents against S. aureus infections such as lysocin E from Lysobacter sp. RH2180-5 81 (23-25) , GPI0363(26), compound 5(27) and iminothiadiazolo-pyrimidinone 82 derivatives(28). Additionally, silkworms have large enough body size to allow 83 administration of precise inoculum and dosage, are economical, easy to handle, and 84 associated with less ethical issues as well as less biohazard potential (29, 30) . The 85 number of bacterial cells required to kill silkworms can be quantitatively determined 86 by the administration of precise inoculum of the bacteria. This allows a direct and 87 easy comparison of the degree of pathogenicity among bacterial strains from their 88 respective lethal dose fifty (LD50) values. We have previously identified novel S. 89 aureus virulence factors using silkworms such as CvfA, CvfB, CvfC(31), SarZ(32) 90 and SA1684(33) that have roles in pathogenicity in mice models. In this regard, the 91 use of silkworm as a model is the unique way for the identification of novel virulence 92 factors of S. aureus that can have roles in pathogenicity to mammals. Since 93 community-acquired MRSA (CA-MRSA) USA300 is hypervirulent compared to the 94 majority of the hospital-acquired MRSAs(34), we used USA300 strain for screening 95 in this study. Here, we performed the first large-scale and quantitative screening of 96 the gene-disrupted mutants of USA300 JE2 from the Nebraska Transposon Mutant 97 Library (NTML)(35) using silkworms. We identified 11 mutants with reduced 98 virulence in silkworms, among which nine had reduced virulence in mice. To our 99 knowledge, this is the first report that uncovers the roles of these genes in 100 aggravating the infection. 101
102
Results 103
Identification of novel S. aureus genes with roles in pathogenicity using 104 silkworms 105
Previous attempts of evaluation of virulence genes in S. aureus by using silkworms 106 have been performed in small scales and with methicillin-susceptible S. aureus 107 (MSSA) strains such as RN4220(31) and . In this study, we 108 performed a large-scale screening of a mutant library of a CA-MRSA USA300 LAC 109 JE2 strain to find genes required for full virulence in silkworms for the first time. At 110 first, a total of 380 gene-disrupted mutants whose gene products were hypothetical 111 proteins and were not tested previously using silkworms(31) were selected for the 112 study. As silkworms can be injected with accurate volumes of inoculum by using 113 syringes, the primary screening was performed by injection of same dilutions (ten-114 fold) of the overnight culture of the strains and observing the survival of the infected 115 silkworms. We obtained 28 strains in the primary screening that did not kill silkworms 116 when the wild-type strain killed all the silkworms (Figure 1a , Supplementary Table  117 S1). Next, we compared the lethal dose fifty (LD50) values, the bacterial dose that 118 kills half of the silkworms, after injecting serial dilutions of the cultures into the 119 silkworm hemolymph. Counting the colony-forming units (CFU) of the injected 120 bacteria was performed separately. Out of 28, 12 strains showed  2 fold higher LD50 121 values than that of the wild-type ( Supplementary Table S1 ). We, then, selected 122 these 12 strains for further examination and found that 11 showed higher LD50 123 values with statistical significance in silkworms compared to that of the wild-type 124 (Figure 1a,b) . The feasibility of accurate inoculum administration and quantitative 125 analysis can be attributed to the discovery of previously unidentified genes with roles 126 in pathogenicity. 127 128
Pathogenicity of the identified mutants in the mouse infection model 129
We evaluated the pathogenicity of the 11 strains in the mouse systemic infection 130 model by examining the microbial burden in organs-heart and kidney of the infected 131 mice. Nine out of 11 strains had significantly reduced microbial survival in at least 132 one of the organs (Figure 2a 
In vitro phenotypes of the mutants 147
We examined the growth rates of all the mutants grown in vitro in TSB medium at 148 37˚C. We found that the doubling times of the mutants were not significantly different 149 from that of the wild-type (Supplementary Figure S1) suggesting that the 150 differences in pathogenicity could not be attributed to differences in growth rates of 151 the strains. To further check whether the phenomena of low pathogenicity is related 152 to the reduction in toxin production, we compared the hemolytic and proteolytic 153 activities of the mutants with those of the wild-type. We found that three strains 154 0904::Tn, 0750::Tn and 0657::Tn had reduced hemolytic activity as determined by a 155 clear zone surrounding the colony in sheep-blood (Figure 3 ) and that 0904::Tn had 156 reduced proteolytic activity as evaluated by a clear zone surrounding the colony in 157 skim milk agar plates (Figure 3) . Besides, the 0904::Tn strain had a reduced 158 pigment production capacity on the sheep blood agar plate (Figure 3) . The reduced 159 pigment and protease production of 0904::Tn were in accordance to previous 160 reports (35, 37) . 161
162
Among the analyzed strains, the LD50 value in silkworm was the highest for the 163 0904::Tn strain which could not lyse sheep red blood cells and casein, and had a 164 reduced pigment production capacity suggesting that the loss of pathogenicity of this 165 strain could be explained at least in part by the reduced toxin production capacity. 166
For the strains with the indistinguishable change in the toxin production capacity, we 167 assume that these genes regulate virulence in S. aureus via pathways other than 168 toxin production and that the loss of pathogenicity could be a result of various host-169 pathogen interplay. This suggested that the candidates identified in this study would 170 have been missed in the in vitro screens, highlighting the importance of in vivo 171 screening system for the screening of genes involved in virulence. 172
173
To understand the properties of these novel virulence factors, we performed a 174 bioinformatic analysis and predicted the functional domains of these proteins. First, 175 based on the description in the GenBank, we found that all but two were categorized 176 as hypothetical proteins. Next, we obtained the complete genome sequences of 328 177 S. aureus strains from GenBank and analyzed the orthologous proteins by 178
Orthofinder 2.2.6(38) as explained previously (39). We found that the nine proteins 179 identified in this study were highly conserved (detected in nearly 97% strains) among 180 different strains of S. aureus while eight strains did not harbor the homologs for five 181 of the identified virulence factors: SAUSA300_0553, SAUSA300_0904, 182 SAUSA300_0942, SAUSA300_1012, and SAUSA300_2320 (Supplementary Table  183 S2). Furthermore, we found that four out of the nine proteins were predicted to be 184 located in the cytoplasm and three in the cytoplasmic membrane; four were 185 predicted to consist of transmembrane helicases; one was predicted to be a 186 secretory protein; and six were categorized to be proteins with either no known 187 homologous superfamily or having an uncharacterized domain ( Table 1) . Detailed 188 analysis of the molecular mechanism of how these proteins act as virulence factors 189 will be the next step in our research. The success of S. aureus to infect host depends on its ability to evade the immune 193 system and acquire nutrition from the host. The genomic analysis of multiple S. 194 aureus indicates the presence of several genes encoding for hypothetical or 195 uncharacterized proteins. Some of these genes are conserved among many S. 196 aureus strains indicating that they might serve as a tool to compete in the host 197 environment. In our study, we found that some of these conserved uncharacterized 198 proteins were, in fact, involved in S. aureus pathogenicity as virulence factors. for target-based screening, it is important to select the virulence factor(s) that are 206 expressed while infecting a host and be responsible for full virulence. We used 207 silkworms for this purpose. Since silkworms are easy to rear in a small space, easy 208 to handle, and special injection techniques are not required, it is possible to inject 209 hundreds of silkworms within an hour. Most importantly, less ethical concerns 210 associated with its use and feasibility of quantitative administration of precise 211 inoculum/dose make the silkworm an excellent model host for screening purposes. 212
The established infection models, activation of innate-immunity by pathogen 213 invasion, treatment by clinically used antimicrobial agents, and presence of basic 214 pharmacokinetic pathways common to mammals advocate that silkworms are 215 suitable for the study of host-pathogen interactions. 216
217
Here, we employed a simple model host-based approach using silkworms and 218 uncovered nine novel genes that are required for full virulence of S. aureus. The 219 success relied on the quantitative screening using silkworms resulting in a high 220 degree of correlation between the virulence in silkworm and mice. Microbes such as 221 S. aureus also take advantage of the host's acquired immunity to establish 222 infection(41), and silkworms only have an innate immune system. Therefore, the use 223 of silkworm model can identify virulence factors that trigger innate immunity and not 224 the acquired immunity. 
Mutant library and bacterial growth conditions 251
The transposon mutant library of S. aureus USA300 strain JE2 referred to as-252
Nebraska Transposon Mutant Library Screening Array was kindly provided by BEI 253 resources (NR-48501). The library consists of gene disruptants of 1920 genes. 254
Single colonies of the wild-type and the gene-disrupted mutants were isolated in 255 tryptic-soy broth (TSB; Becton Dickinson and Company, Franklin Lakes NJ, USA) 256 agar plates with supplementation of 5 µg/ml erythromycin (Wako Pure Chemicals, 257
Tokyo, Japan) for the mutants. A single colony was then inoculated in 5 ml of TSB or 258 TSB supplemented with erythromycin and grown overnight by shaking at 37˚C to 259 prepare the full growth. 260 261
Silkworm rearing and infection assay 262
Silkworms were raised as previously described(26). The fifth instar larvae were fed 263 an antibiotic-free artificial diet for one day, and 50 µl of each dilution of the strains 264 was injected into the hemolymph of larvae (n=10) using a 1-ml syringe (Terumo 265
Corporation, Tokyo, Japan) equipped with a 27-gauge needle (Terumo Corporation). 266
The silkworms were then kept at 27˚C, and survival was observed. 267 268
Screening of gene-disrupted mutants for reduced pathogenicity in silkworms 269
The screening was performed in two stages: 270
Primary screening: The full growth of the wild-type JE2 and the selected 380 gene-271 disrupted mutants was diluted tenfold with sterile 0.9% NaCl (Otsuka Normal Saline, 272 Otsuka Pharmaceutical Factory, Inc., Tokyo, Japan) and injected into silkworms. 273
Strain with mutation in cvfB gene, SAUSA300_1284 was used as a positive 274 control(31). Those strains with reduced silkworm killing ability under the following 275 criteria were selected as hits: survival of at least 50% silkworms when all silkworms 276 injected with the wild-type died and all silkworms injected with the vehicle survived. 37˚C. The lethal dose fifty (LD50) values of each strain were determined from the 285 CFU and survival of silkworms. Strains that showed significantly higher LD50 values 286 than that of the wild-type were selected for further experiments. 287 288
Pathogenicity of the strains in mice 289
All mouse protocols were approved by the Teikyo University Animal Ethics 290
Committee. Overnight cultures of the strains were diluted 100 fold and incubated at 291 37˚C with shaking for 16 hours. The resulting cultures were then centrifuged, washed 292
with Phosphate Buffered Saline (PBS; Wako Pure Chemicals), and suspended in 293 PBS to adjust the turbidity (A600) to 0.7 using a spectrophotometer (UV-1280 294 Shimadzu Corp., Kyoto, Japan). Mice (ICR, female, eight weeks, Charles River 295 Laboratories Japan Inc., Kanagawa, Japan) were injected with 200 µl of the 296 prepared suspension of strains intravenously into the tail vein. The injected 297 suspensions were diluted, spread on agar plates, and appeared colonies were 298
counted to obtain the injected CFU of each strain. After 24 hours, organs (kidney and 299 heart) of the infected mice were isolated, suspended in PBS and homogenized, 300 diluted, and spread on agar plates. Appeared colonies were counted after overnight 301 incubation of the plates at 37˚C. 302 303
Determination of hemolytic and proteolytic activities 304
The strains were cultured in TSB or TSB supplemented with erythromycin at 37˚C 305 
